IN2015DN00085A - - Google Patents

Download PDF

Info

Publication number
IN2015DN00085A
IN2015DN00085A IN85DEN2015A IN2015DN00085A IN 2015DN00085 A IN2015DN00085 A IN 2015DN00085A IN 85DEN2015 A IN85DEN2015 A IN 85DEN2015A IN 2015DN00085 A IN2015DN00085 A IN 2015DN00085A
Authority
IN
India
Prior art keywords
compounds
preparation
general formula
methods
well
Prior art date
Application number
Other languages
English (en)
Inventor
Volker Schulze
Franz Josef Mais
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Publication of IN2015DN00085A publication Critical patent/IN2015DN00085A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN85DEN2015 2012-07-10 2013-07-03 IN2015DN00085A (uk)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP12175640 2012-07-10
EP12185590 2012-09-24
EP13170585 2013-06-05
PCT/EP2013/064017 WO2014009219A1 (en) 2012-07-10 2013-07-03 Method for preparing substituted triazolopyridines

Publications (1)

Publication Number Publication Date
IN2015DN00085A true IN2015DN00085A (uk) 2015-05-29

Family

ID=48793197

Family Applications (1)

Application Number Title Priority Date Filing Date
IN85DEN2015 IN2015DN00085A (uk) 2012-07-10 2013-07-03

Country Status (24)

Country Link
US (1) US9388177B2 (uk)
EP (1) EP2872506A1 (uk)
JP (1) JP6238979B2 (uk)
KR (1) KR20150040845A (uk)
CN (1) CN104603136B (uk)
AP (1) AP3778A (uk)
AU (1) AU2013289381A1 (uk)
BR (1) BR112015000308A2 (uk)
CA (1) CA2878481A1 (uk)
CL (1) CL2015000038A1 (uk)
CO (1) CO7160002A2 (uk)
CR (1) CR20150006A (uk)
DO (1) DOP2015000007A (uk)
EA (1) EA027544B1 (uk)
HK (1) HK1206731A1 (uk)
IL (1) IL236265A (uk)
IN (1) IN2015DN00085A (uk)
MX (1) MX2015000348A (uk)
NZ (1) NZ703020A (uk)
PE (1) PE20150354A1 (uk)
PH (1) PH12015500061A1 (uk)
SG (1) SG11201408419QA (uk)
TN (1) TN2015000008A1 (uk)
WO (1) WO2014009219A1 (uk)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2914521A1 (en) * 2013-06-07 2014-12-11 Bayer Pharma Aktiengesellschaft Substituted triazolopyridines having activity as mps-1 inhibitors
CN105377848A (zh) * 2013-06-11 2016-03-02 拜耳制药股份公司 取代的三唑并吡啶的前体药物衍生物
EA201600003A1 (ru) 2013-06-11 2016-06-30 Байер Фарма Акциенгезельшафт КОМБИНАЦИИ ДЛЯ ЛЕЧЕНИЯ РАКА, СОДЕРЖАЩИЕ ИНГИБИТОР Mps-1 КИНАЗЫ И ИНГИБИТОР МИТОЗА
ES2966392T3 (es) 2015-04-17 2024-04-22 Crossfire Oncology Holding B V Biomarcadores pronósticos para quimioterapia inhibidora de TTK
TW201800408A (zh) 2016-06-15 2018-01-01 拜耳製藥公司 Mps-1抑制劑

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2003030937A1 (ja) * 2001-10-05 2005-01-20 小野薬品工業株式会社 ミトコンドリアルベンゾジアゼピン受容体アンタゴニストからなるストレス疾患の治療剤
JP2007537296A (ja) * 2004-05-14 2007-12-20 アボット・ラボラトリーズ 治療薬としてのキナーゼ阻害薬
UA89503C2 (uk) * 2004-09-13 2010-02-10 Х. Луннбек А/С Заміщені похідні аніліну
US7524860B2 (en) * 2004-10-07 2009-04-28 Pfizer Inc. Antibacterial agents
US20060194823A1 (en) * 2004-12-22 2006-08-31 Georg Kettschau Sulfonamido-macrocycles as Tie2 inhibitors and the salts thereof, a pharmaceutical composition comprising these compounds, the method of preparing and the use thereof
WO2007145921A1 (en) * 2006-06-06 2007-12-21 Schering Corporation Imidazopyrazines as protein kinase inhibitors
EP1870416A1 (en) * 2006-06-21 2007-12-26 Bayer Schering Pharma Aktiengesellschaft Sulphonamido-macrocycles as tie2 inhibitors
CN103641829A (zh) 2006-08-30 2014-03-19 塞尔佐姆有限公司 作为激酶抑制剂的三唑衍生物
JO3598B1 (ar) * 2006-10-10 2020-07-05 Infinity Discovery Inc الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
JP2010533680A (ja) 2007-07-18 2010-10-28 ノバルティス アーゲー 二環ヘテロアリール化合物およびそれらのキナーゼ阻害剤としての使用
AU2008290330A1 (en) 2007-08-23 2009-02-26 Astrazeneca Ab 2-anilinopurin-8-ones as inhibitors of TTK/Mps1 for the treatment of proliferative disorders
EA201070328A1 (ru) 2007-08-31 2010-08-30 Мерк Сероно С.А. Соединения триазолопиридина и их применение в качестве ингибиторов ask
GB0719803D0 (en) 2007-10-10 2007-11-21 Cancer Rec Tech Ltd Therapeutic compounds and their use
GB0724342D0 (en) * 2007-12-13 2008-01-30 Prolysis Ltd Anitbacterial compositions
WO2009137322A2 (en) * 2008-05-05 2009-11-12 The Trustees Of The University Of Pennsylvania Processes for the preparation of biphenyl compounds
WO2009155527A2 (en) * 2008-06-19 2009-12-23 Progenics Pharmaceuticals, Inc. Phosphatidylinositol 3 kinase inhibitors
JP2012517971A (ja) 2009-02-13 2012-08-09 フォーヴィア・ファーマシューティカルズ キナーゼ阻害薬としての[1,2,4]トリアゾロ[1,5−a]ピリジン類
JP6168773B2 (ja) 2009-04-29 2017-07-26 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH 置換イミダゾキノキサリン
WO2010141796A2 (en) * 2009-06-05 2010-12-09 Cephalon, Inc. PREPARATION AND USES OF 1,2,4-TRIAZOLO [1,5a] PYRIDINE DERIVATIVES
WO2010141360A1 (en) * 2009-06-05 2010-12-09 Merck Sharp & Dohme Corp. Biaryl benzotriazole derivatives
US9340528B2 (en) 2009-09-04 2016-05-17 Bayer Pharma Aktiengesellschaft Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors
EP2343297A1 (en) 2009-11-30 2011-07-13 Bayer Schering Pharma AG Triazolopyridines
EP2343295A1 (en) 2009-11-30 2011-07-13 Bayer Schering Pharma AG Triazolopyridine derivates
EP2343294A1 (en) * 2009-11-30 2011-07-13 Bayer Schering Pharma AG Substituted triazolopyridines
UY33452A (es) 2010-06-16 2012-01-31 Bayer Schering Pharma Ag Triazolopiridinas sustituidas
WO2012044567A2 (en) * 2010-09-30 2012-04-05 Merck Sharp & Dohme Corp. Imidazole derivatives
PT2699575E (pt) * 2011-04-21 2015-07-29 Bayer Ip Gmbh Triazolopiridinas
WO2012160029A1 (en) * 2011-05-23 2012-11-29 Bayer Intellectual Property Gmbh Substituted triazolopyridines
UA112096C2 (uk) * 2011-12-12 2016-07-25 Байєр Інтеллектуал Проперті Гмбх Заміщені триазолопіридини та їх застосування як інгібіторів ttk

Also Published As

Publication number Publication date
EP2872506A1 (en) 2015-05-20
CN104603136A (zh) 2015-05-06
AP2014008177A0 (en) 2014-12-31
US9388177B2 (en) 2016-07-12
EA201590116A1 (ru) 2015-07-30
CR20150006A (es) 2015-02-16
EA027544B1 (ru) 2017-08-31
MX2015000348A (es) 2015-04-14
IL236265A (en) 2017-07-31
WO2014009219A1 (en) 2014-01-16
BR112015000308A2 (pt) 2017-06-27
KR20150040845A (ko) 2015-04-15
JP2015523372A (ja) 2015-08-13
TN2015000008A1 (en) 2016-06-29
AU2013289381A1 (en) 2015-01-22
US20150148542A1 (en) 2015-05-28
PH12015500061A1 (en) 2015-03-02
DOP2015000007A (es) 2015-02-15
SG11201408419QA (en) 2015-01-29
CL2015000038A1 (es) 2015-03-13
IL236265A0 (en) 2015-02-26
HK1206731A1 (en) 2016-01-15
CN104603136B (zh) 2017-06-27
AP3778A (en) 2016-08-31
NZ703020A (en) 2017-08-25
JP6238979B2 (ja) 2017-11-29
CO7160002A2 (es) 2015-01-15
CA2878481A1 (en) 2014-01-16
PE20150354A1 (es) 2015-03-21

Similar Documents

Publication Publication Date Title
NZ743274A (en) Substituted tricyclic compounds as fgfr inhibitors
PH12015502839A1 (en) Antiviral compounds
ZA201500316B (en) Novel compound with effects of thrombolysis, free radical scavenging and thrombus-targeting as well as preparation method and use thereof
IL235944A0 (en) β-lactamase inhibitor compounds, preparations containing them, methods for their preparation and their uses
AU2012213775A8 (en) 7-azaindole derivatives
NZ704662A (en) Crystalline forms of the prolyl hydroxylase inhibitor [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid
IN2014MN02598A (uk)
MX352881B (es) Metodos y compuestos utiles en la sintesis de antagonistas del receptor de orexina 2.
EA201590887A1 (ru) Композиция
SG195086A1 (en) Compounds containing hydrido-tricyano-borate anions
IN2014DN06104A (uk)
JO3154B1 (ar) عوامل مضادة لـ trpv4
NZ607149A (en) Galacto-oligosaccharide-containing composition and a method of producing it
PH12015501175A1 (en) Substituted pyridopyrazines as syk inhibitors
MX2014005510A (es) Nuevas composiciones, produccion de las mismas y uso de las mismas para la produccion de poliamidas coladas.
MX2014010433A (es) Nueva forma cristalina de sulfato de sitagliptina.
MX2012010127A (es) Derivados de aminoindanos, su preparacion y su aplicacion en terapeuticos.
GEP201706626B (en) Synthesis of (s)-nifuratel
PH12015500061A1 (en) Method for preparing substituted triazolopyridines
MX347541B (es) Analogos de acido sialico.
GB201107985D0 (en) Process
UA117567C2 (uk) Композиція, яка стимулює лактацію, на основі фосфатидилсерину
AU2012248013B2 (en) Intermediate for synthesizing caspofungin and preparation method therefor
IN2014DN10135A (uk)
MX2015005510A (es) Forma salina solida de la alfa-6-mpeg6-o-hidroxicodona como agonistas opioides y sus usos.